BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2000
View Archived Issues
Safety of clopidogrel shown to be superior to ticlopidine after coronary stenting
Read More
Smoking linked to increased TF expression in atherosclerotic plaques
Read More
Anadys signs antifungal collaboration with Pharmacia
Read More
McGill University licenses fungal genomics technology to Mycota Biosciences
Read More
Avanir forms subsidiary to exploit human MAb technology
Read More
CuraGen and Abgenix select 24 antibody drug targets for cancer indications
Read More
Bioniche reports preclinical findings for MCC in prostate cancer
Read More
Copernicus Therapeutics awarded SBIR grant to develop episomal vectors for breast cancer therapy
Read More
Therapies aimed at reducing free radicals may innovate treatment of septic shock
Read More
Research associates synapsins with cyclosporine-induced hypertension
Read More
Researchers establish the effect of beta-blocker nebivolol on nitric oxide production
Read More
Antiretroviral therapy reduces but does not eliminate seminal HIV shedding
Read More
Medicis obtains rights to Corixa's psoriasis product PVAC
Read More
MCA lifts clinical hold on Vasomax
Read More
Positive phase II results reported for IoGen in FBD
Read More
United submits first sections of Uniprost NDA to FDA for pulmonary hypertension
Read More
Genetic sequence of cholera bacterium published
Read More
Antineoplastic agents under development at Merck & Co.
Read More
New compounds interacting with glutathione reductase useful for cataracts, etc.
Read More
New compounds under development at BioChem Pharma for treatment of antiviral infections
Read More
Fujisawa receives patent for imidazole agents
Read More
Novel thrombin inhibitors under study at LG Chemical
Read More
Seven key sessions and symposia from XXII ESC Congress available to Daily Essentials readers
Read More
Novel series of group II mGlu receptor agonists described at ACS meeting
Read More
deCODE Genetics and Roche reach milestone in Alzheimer's research
Read More
